Concepedia

Surabhi Srinivasan

SS

Statistics

Publications

5

Citations

247

H-Index

5

Active since

2014

Affiliations

Allogene Therapeutics (United States)(Current)

Pfizer (United States)

Surabhi Srinivasan is an author at Allogene Therapeutics (United States) specializing in immunology, antibody epitope mapping, and antibody library construction.

Publications per year

2014–2024

5

Publications

5

Exposure of Epitope Residues on the Outer Face of the Chikungunya Virus Envelope Trimer Determines Antibody Neutralizing Efficacy

Rachel H. Fong, Soma S. R. Banik, Kimberly Mattia et al. · Journal of Virology · 2014 · 92 citations · Full text

, , +15

Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma

Siler H. Panowski, Surabhi Srinivasan, Nguyêñ Duy Tân et al. · Cancer Research · 2022 · 88 citations

, , +17

Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies

Thomas Van Blarcom, Kevin C. Lindquist, Zea Melton et al. · mAbs · 2017 · 40 citations · Full text

, , +17

Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents

Mario L. Marques‐Piubelli, Bijender Kumar, Rafet Başar et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2024 · 15 citations · Full text

, , +15

Investigation of ALLO-316: A Fratricide-Resistant Allogeneic CAR T Targeting CD70 As a Potential Therapy for the Treatment of AML

Surabhi Srinivasan, Nguyêñ Duy Tân, Hsin‐Yuan Cheng et al. · Blood · 2020 · 12 citations

, , +13

1–5 of 5